The Liver Meeting 2026
Talk TLM Theater track
The Pancreas, the Bile Duct, and Beyond: Management With the First FDA-Approved Treatment for IgG4-Related Disease
Sat, Nov 7, 2026 · 3:30–4:15 PM MST Convention Center: TLM Theater 3, Hall F, Colorado Convention Center
About this session
Highlight expert perspectives on diagnosing IgG4-RD and its manifestations, including type 1 AIP and IgG4-related sclerosing cholangitis. Review Importance of assessing patients with IgG4-RD for extra-GI manifestations and highlight clinical trial data. Industry Supporter: Amgen
